Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 679.92 million compared to CNY 493.65 million a year ago. Net income was CNY 158.28 million compared to CNY 105.66 million a year ago.

Basic earnings per share from continuing operations was CNY 1.4143 compared to CNY 1.0786 a year ago.